Insights
25.05.18
By Sterling Pharma Solutions

While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by the pharmaceutical industry – primarily because manufacturing pharmaceuticals is more complex and requires more reactions and purification steps.

Despite the added complexity, there are numerous benefits to manufacturing in this way when compared to batch production, including the potential savings of time and resource and the improvements to process efficiencies.

In this article with Contract Pharma, Mark Muldowney, Head of Technology and Innovation at Sterling Pharma Solutions examines the considerations that need to be taken when exploring the viability of continuous processing and the effect continuous flow technologies could have on the industry in future.

Read the full article here.